Variables | Total (n = 201) | TP (n = 50) | TC (n = 151) | p |
---|---|---|---|---|
Age, years, n(%) | 0.738 | |||
< 65 | 143 (71.1) | 37 (74) | 106 (70.2) | |
≥ 65 | 58 (28.9) | 13 (26) | 45 (29.8) | |
Sex, n(%) | 0.339 | |||
Male | 175 (87.1) | 46 (92) | 129 (85.4) | |
Female | 26 (12.9) | 4 (8) | 22 (14.6) | |
ECOG, n(%) | 0.778 | |||
0 | 183 (91.0) | 45 (90) | 138 (91.4) | |
1 | 18 ( 9.0) | 5 (10) | 13 (8.6) | |
Smoking, n(%) | 0.122 | |||
Yes | 137 (68.2) | 39 (78) | 98 (64.9) | |
No | 64 (31.8) | 11 (22) | 53 (35.1) | |
Drinking, n(%) | 0.36 | |||
Yes | 132 (65.7) | 36 (72) | 96 (63.6) | |
No | 69 (34.3) | 14 (28) | 55 (36.4) | |
Tumor location, n (%) | 0.284 | |||
Uper | 30 (14.9) | 4 (8) | 26 (17.2) | |
Midle | 71 (35.3) | 19 (38) | 52 (34.4) | |
Lower | 100 (49.8) | 27 (54) | 73 (48.3) | |
Clinical T stage, n (%) | 0.088 | |||
T2 | 12 ( 6.0) | 5 (10) | 7 (4.6) | |
T3 | 160 (79.6) | 36 (72) | 124 (82.1) | |
T4a | 17 ( 8.5) | 3 (6) | 14 (9.3) | |
T4b | 12 ( 6.0) | 6 (12) | 6 (4) | |
Clinical N stage, n (%) | 0.749 | |||
N0 | 4 ( 2.0) | 1 (2) | 3 (2) | |
N1 | 73 (36.3) | 21 (42) | 52 (34.4) | |
N2 | 100 (49.8) | 22 (44) | 78 (51.7) | |
N3 | 24 (11.9) | 6 (12) | 18 (11.9) | |
Stage, n (%) | 0.657 | |||
II | 8 ( 4.0) | 3 (6) | 5 (3.3) | |
III | 147 (73.1) | 36 (72) | 111 (73.5) | |
IVA | 46 (22.9) | 11 (22) | 35 (23.2) |